How oxygenation shapes immune responses: Emerging roles for physioxia and pathological hypoxia

AS Mirchandani, MA Sanchez-Garcia… - Nature Reviews …, 2024 - nature.com
Most eukaryotes require oxygen for their survival and, with increasing multicellular
complexity, oxygen availability and delivery rates vary across the tissues of complex …

Unraveling the enigma of tumor-associated macrophages: challenges, innovations, and the path to therapeutic breakthroughs

S Shao, H Miao, W Ma - Frontiers in Immunology, 2023 - frontiersin.org
Tumor-associated macrophages (TAMs) are integral to the tumor microenvironment (TME),
influencing cancer progression significantly. Attracted by cancer cell signals, TAMs exhibit …

Role of hypoxia-inducible factor 1 in type 1 diabetes

RR Fagundes, A Zaldumbide, CT Taylor - Trends in Pharmacological …, 2024 - cell.com
Abstract Type 1 diabetes (T1D) is a common autoimmune disease in which dysregulated
glucose metabolism is a key feature. T1D is both poorly understood and in need of improved …

CAR-T cell technologies that interact with the tumour microenvironment in solid tumours

CA Taylor, M Glover, J Maher - Expert Review of Clinical …, 2024 - Taylor & Francis
Introduction Chimeric antigen receptor (CAR) T-cells have emerged as a ground-breaking
therapy for the treatment of hematological malignancies due to their capacity for rapid tumor …

A high-density microfluidic bioreactor for the automated manufacturing of CAR T cells

WX Sin, NS Jagannathan, DBL Teo, F Kairi… - Nature Biomedical …, 2024 - nature.com
The manufacturing of autologous chimaeric antigen receptor (CAR) T cells largely relies
either on fed-batch and manual processes that often lack environmental monitoring and …

Epigenetic regulation of tumor immunity

L Pang, F Zhou, Y Liu, H Ali, F Khan, AB Heimberger… - 2024 - europepmc.org
Although cancer has long been considered a genetic disease, increasing evidence shows
that epigenetic aberrations play a crucial role in affecting tumor biology and therapeutic …

Neutrophil-mediated hypoxia drives pathogenic CD8 T cell responses in cutaneous leishmaniasis

EA Fowler, CF Amorim, K Mostacada… - The Journal of …, 2024 - Am Soc Clin Investig
Cutaneous leishmaniasis caused by Leishmania parasites exhibits a wide range of clinical
manifestations. Although parasites influence disease severity, cytolytic CD8 T cell responses …

[HTML][HTML] CAR-T cell expansion platforms yield distinct T cell differentiation states

HW Song, M Prochazkova, L Shao, R Traynor… - Cytotherapy, 2024 - Elsevier
With investigators looking to expand engineered T cell therapies such as CAR-T to new
tumor targets and patient populations, a variety of cell manufacturing platforms have been …

Nanoreactors with Cascade Catalytic Activity Reprogram the Tumor Microenvironment for Enhanced Immunotherapy by Synchronously Regulating Treg and …

Y Fu, Y Zhang, Y Zhang, R Li, M Yang… - … Applied Materials & …, 2024 - ACS Publications
Immunotherapy has been extensively utilized and studied as a prominent therapeutic
strategy for tumors. However, the presence of a hypoxic immunosuppressive tumor …

Metabolic immunoengineering approaches to enhance CD8+ T cell-based cancer immunotherapy

B Feng, R Li, W Li, L Tang - Cell Systems, 2024 - cell.com
Many cancer immunotherapies rely on robust CD8+ T cells capable of eliminating cancer
cells and establishing long-term tumor control. Recent insights into immunometabolism …